Recurrent ischemic stroke as an initial manifestation of an concealed pancreatic adenocarcinoma: Trousseau's syndrome

被引:12
作者
Giray, Semih [1 ]
Sarica, Feyzi Birol [2 ]
Arlier, Zulfikar [1 ]
Bal, Nebil [3 ]
机构
[1] Baskent Univ, Fac Med, Dept Neurol, TR-01250 Adana, Turkey
[2] Baskent Univ, Fac Med, Dept Neurosurg, TR-01250 Adana, Turkey
[3] Baskent Univ, Fac Med, Dept Pathol, TR-01250 Adana, Turkey
关键词
disseminated intravascular coagulation; ischemic stroke; pancreas adenocarcinoma; Trousseau's syndrome; OCCULT CANCER; COAGULATION; DISEASE;
D O I
10.3760/cma.j.issn.0366-6999.2011.04.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In rare instances, stroke may preceed a diagnosis of cancer and be the first clinical evidence of an underlying malignancy. Cerebral infarction mostly complicates lymphomas, carcinomas, and solid tumors. Malignancy-related thromboembolism can present as acute cerebral infarction, nonbacterial thrombotic endocarditis and migratory thrombophlebitis. It is generally attributed to a cancer-related hypercoagulable period, chronic dissemiated intravascular coagulopathy (DIC), or tumor embolism. We reported a case of malignancy-releated thromboembolism from an undiagnosed pancreatic adenocarcinoma in a 54-year-old man, who presented with recurrent ischemic stroke due to chronic DIC. He died of the underlying malignancy despite the appropriate institution of anticoagulation therapy. This case emphasizes that cerebral infarction may be the first manifestation of an undiagnosed cancer. If there is laboratory or clinical evidence associated with DIC, patients with a cerebral infarct of an unknown etiology should be investigated for a malignant process. The optimal method of anticoagulation in cancer patients with thromboembolic disease (TED) remains unclear. Chin Med J 2011;124(4):637-640
引用
收藏
页码:637 / 640
页数:4
相关论文
共 17 条
  • [1] COAGULATION ABNORMALITIES IN MALIGNANCY - A REVIEW
    BICK, RL
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1992, 18 (04) : 353 - 372
  • [2] Coagulation disorders in cancer
    Goad, KE
    Gralnick, HR
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (02) : 457 - +
  • [3] CEREBROVASCULAR COMPLICATIONS IN PATIENTS WITH CANCER
    GRAUS, F
    ROGERS, LR
    POSNER, JB
    [J]. MEDICINE, 1985, 64 (01) : 16 - 35
  • [4] Cancer and thromboembolic disease: pathogenic mechanisms
    Lee, AY
    [J]. CANCER TREATMENT REVIEWS, 2002, 28 (03) : 137 - 140
  • [5] The thrombophilic state induced by therapeutic agents in the cancer patient
    Lee, AYY
    Levine, MN
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (02) : 137 - 145
  • [6] MINNA JD, 1989, CANC PRINCIPLES PRAC, P1920
  • [7] NASCHITZ JE, 1992, CANCER, V69, P2712, DOI 10.1002/1097-0142(19920601)69:11<2712::AID-CNCR2820691114>3.0.CO
  • [8] 2-H
  • [9] ARTERIAL OCCLUSIVE DISEASE IN OCCULT CANCER
    NASCHITZ, JE
    YESHURUN, D
    ABRAHAMSON, J
    [J]. AMERICAN HEART JOURNAL, 1992, 124 (03) : 738 - 745
  • [10] Stroke as the first manifestation of a concealed pancreatic neoplasia
    Pérez-Lázaro, C
    Santos, S
    Morales-Rull, JL
    Garcées-Redondo, M
    del Corral-Beamonte, E
    Fabre-Pi, O
    Lépez-Núñez, C
    Pascual-Millán, LF
    del Val, LJL
    Cajal, SRY
    [J]. REVISTA DE NEUROLOGIA, 2004, 38 (04) : 332 - 335